ARTICLE | Company News
Millennium, Bayer deal
October 30, 2000 8:00 AM UTC
MLNM said it has delivered more than 70 disease-relevant validated drug targets to BAYG for high throughput screening or lead identification under the companies' alliance, for which it has received fe...